Hyphens Pharma International Limited announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was SGD 65.376 million compared to SGD 61.640 million a year ago. Net income was SGD 4.315 million compared to SGD 4.282 million a year ago. Basic earnings per share from continuing operations was SGD 0.0144 compared to SGD 0.0143 a year ago. Diluted earnings per share from continuing operations was SGD 0.0143 compared to SGD 0.0143 a year ago.